Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA450755
Max Phase: Preclinical
Molecular Formula: C35H39N3O10
Molecular Weight: 661.71
Molecule Type: Small molecule
Associated Items:
ID: ALA450755
Max Phase: Preclinical
Molecular Formula: C35H39N3O10
Molecular Weight: 661.71
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C/C=C(/C)C(=O)OC[C@H]1c2c(c(OC(C)=O)c(C)c(OC)c2OC(C)=O)C[C@H]2[C@H]3C4=C(C[C@@H]([C@H](C#N)N12)N3C)C(=O)C(C)=C(OC)C4=O
Standard InChI: InChI=1S/C35H39N3O10/c1-10-15(2)35(43)46-14-25-26-21(31(47-18(5)39)17(4)33(45-9)34(26)48-19(6)40)12-23-28-27-20(29(41)16(3)32(44-8)30(27)42)11-22(37(28)7)24(13-36)38(23)25/h10,22-25,28H,11-12,14H2,1-9H3/b15-10-/t22-,23-,24-,25-,28-/m0/s1
Standard InChI Key: HODZWRQXYVCJIV-BVQANZCBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 661.71 | Molecular Weight (Monoisotopic): 661.2635 | AlogP: 2.98 | #Rotatable Bonds: 7 |
Polar Surface Area: 161.77 | Molecular Species: NEUTRAL | HBA: 13 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 3.10 | CX LogP: 3.45 | CX LogD: 3.45 |
Aromatic Rings: 1 | Heavy Atoms: 48 | QED Weighted: 0.18 | Np Likeness Score: 2.05 |
1. Amnuoypol S, Suwanborirux K, Pummangura S, Kubo A, Tanaka C, Saito N.. (2004) Chemistry of renieramycins. Part 5. Structure elucidation of renieramycin-type derivatives O, Q, R, and S from thai marine sponge Xestospongia species pretreated with potassium cyanide., 67 (6): [PMID:15217287] [10.1021/np030534o] |
2. Fang Y, Li H, Ji B, Cheng K, Wu B, Li Z, Zheng C, Hua H, Li D.. (2021) Renieramycin-type alkaloids from marine-derived organisms: Synthetic chemistry, biological activity and structural modification., 210 [PMID:33333398] [10.1016/j.ejmech.2020.113092] |
Source(1):